Insomnia is the most common sleep disorder with over 55 million Americans suffering from chronic insomnia. Our partners at Ebb™ Therapeutics recently launched Ebb Insomnia Therapy, a clinically-proven wearable device that delivers safe and effective insomnia treatment. In close collaboration with Ebb Therapeutics, Tactile helped design the first and only FDA-cleared device that reduces the time it takes to fall asleep and enter deep, restorative sleep. With product shipments beginning this fall, Ebb Insomnia Therapy includes an intelligent bedside temperature controller with a comfortable headband that provides precise cooling throughout the night. Congrats to Ebb Therapeutics on the launch! More information at www.ebbsleep.com.